Welcome to our dedicated page for Sabra Health Care Reit news (Ticker: SBRA), a resource for investors and traders seeking the latest updates and insights on Sabra Health Care Reit stock.
Sabra Health Care REIT, Inc. reports developments tied to its role as a self-administered, self-managed healthcare real estate investment trust. Through subsidiaries, the company owns and invests in real estate serving the healthcare industry in the United States and Canada, with property categories that include nursing facilities, assisted living centers and mental health facilities.
Recurring news includes quarterly earnings releases and conference calls, common dividend declarations, investor and real estate conference participation, and capital-structure or material-agreement updates associated with its REIT financing and portfolio activities.
Sabra Health Care REIT (Nasdaq: SBRA) announced participation in the 2021 NIC Fall Conference from November 1-3, 2021, at the Marriott Marquis in Houston, Texas. Key company representatives include Chief Investment Officer Talya Nevo-Hacohen and Executive Vice President of Investments Darrin Smith. Sabra, based in Maryland, operates as a self-administered, self-managed real estate investment trust dedicated to healthcare real estate in the U.S. and Canada.
Sabra Health Care REIT (NASDAQ: SBRA) announced on October 15, 2021, the closing of a $290 million mortgage loan for six addiction treatment centers operated by Recovery Centers of America. The total loan is $325 million, with a remaining tranche of $35 million contingent upon performance. Additionally, Sabra acquired a 113-unit senior property in Jasper, Indiana, for $26.3 million, entering a 15-year lease with a starting rate of 6.93%. On October 1, 2021, Sabra transitioned three skilled nursing facilities to affiliates of The Ensign Group under a 20-year lease with initial rent of $1.9 million.
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced the pricing of an underwritten public offering of 6.8 million shares, with an additional 1.02 million shares option for underwriters. The offering is projected to close on October 15, 2021, aiming for gross proceeds of approximately $98.9 million, potentially $113.8 million if the additional share option is fully exercised. Proceeds will fund a $325 million mortgage loan to Recovery Centers of America and may also repay borrowings on its revolving credit facility.
Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has launched an underwritten public offering of 6.8 million shares of common stock, with a potential additional 1.02 million shares for underwriters. The net proceeds, anticipated to be $325 million, will primarily finance a mortgage loan to Recovery Centers of America, secured by eight addiction treatment centers, or repay existing revolving credit facility borrowings. Joint book-running managers include Citigroup, Barclays, and Wells Fargo Securities. This offering follows an effective shelf registration statement with the SEC.
Sabra Health Care REIT (NASDAQ: SBRA) announced that Chief Investment Officer Talya Nevo-Hacohen will attend the 72nd AHCA/NCAL Convention and Expo on October 12, 2021. Nevo-Hacohen will participate in the Capital Solutions Panel, discussing financing strategies for healthcare providers of all sizes. The event will take place at the Gaylord National Resort and Convention Center in Maryland. Sabra focuses on owning and investing in healthcare-related real estate across the United States and Canada.
Sabra Health Care REIT, Inc. (SBRA) announced its subsidiary, Sabra Health Care Limited Partnership, has priced $800 million in 3.200% senior notes due 2031. The offering, under an SEC registration statement, is expected to close on September 30, 2021. Proceeds will be used to redeem existing 4.80% senior notes due 2024 and repay $345 million in term loans maturing on September 9, 2023, alongside funding future investments and general corporate purposes. The offering is managed by Wells Fargo Securities, BofA Securities, Credit Agricole, and J.P. Morgan.
Sabra Health Care REIT (SBRA) announced plans to expand its partnership with Recovery Centers of America (RCA) by providing a $325 million mortgage loan secured by eight addiction treatment centers. The loan will yield an interest rate of 7.5% and a five-year term, allowing Sabra a first offer to acquire the centers. Despite improving occupancy rates in their portfolio, Sabra faces challenges from COVID-19 variants impacting restrictions and labor shortages. Additionally, Avamere, a key partner, is encountering financial strains, potentially affecting future lease obligations.
Sabra Health Care REIT, Nasdaq: SBRA, announced participation in BofA’s 2021 Global Real Estate Conference on September 23, 2021. Key executives attending include Rick Matros (Chair & CEO), Harold Andrews (CFO), Talya Nevo-Hacohen (CIO), and Michael Costa (EVP of Finance & CAO). The company operates as a self-administered, self-managed real estate investment trust, investing in healthcare-related real estate across the United States and Canada.
Sabra Health Care REIT (NASDAQ: SBRA) announced that key executives, including Chair and CEO Rick Matros, CFO Harold Andrews, CIO Talya Nevo-Hacohen, and EVP Michael Costa, will participate in BMO's 2021 Real Estate Conference virtually on September 14, 2021. This event highlights the company's ongoing commitment to the healthcare real estate sector.
Sabra operates as a self-administered, self-managed REIT, investing in properties serving the healthcare industry across the U.S. and Canada.
Sabra Health Care REIT (Nasdaq: SBRA) reported a second-quarter net loss of $(0.61) per diluted common share, including a $(0.76) impairment charge related to the Enlivant Joint Venture. Despite challenges, EBITDARM Coverage for key segments improved, achieving 2.27x, benefiting from a 99.8% rent collection rate during the pandemic. The company plans to exit the Enlivant Joint Venture, recognizing a $164.1 million impairment. With liquidity of approximately $1.1 billion, Sabra has positioned itself for future growth, while maintaining a quarterly cash dividend of $0.30.